Clinical Trials Logo

Post Stroke Epilepsy clinical trials

View clinical trials related to Post Stroke Epilepsy.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05987397 Recruiting - Clinical trials for Post Stroke Epilepsy

Exploring the Preventive Effect of Mitochondrial Protective Agent Idebenone on Post-stroke Epilepsy

Start date: July 5, 2023
Phase: Phase 4
Study type: Interventional

According to the random number table, all patients were divided into short-term treatment group, long-term treatment group and non-intervention stroke control group according to the proportion of (1:1:1) epilepsy disease modifier idebenone. Patients in the short-term treatment group will take idebenone for a total course of 14 days (acute period) after stroke, and patients in the long-term treatment group will take idebenone for a total course of 3 months after stroke.

NCT ID: NCT05864547 Recruiting - Stroke Clinical Trials

Predisposing Factors for Post-stroke Epilepsy

PRESTEP
Start date: May 8, 2023
Phase:
Study type: Observational [Patient Registry]

The goal of this observational study is to learn about epilepsy after a stroke (post-stroke epilepsy). The main questions it aims to answer are: - What make some patients develop epilepsy after a stroke? - Does sleep have an impact on the development of post-stroke epilepsy? Participants will undergo: - Electroencephalography (EEG) - Magnetic resonance imaging (MRI) - Polysomnography (only patients) Blood tests will also be taken. The patient group will be compared to the healthy controls. Researchers will also look into medical records of stroke patients hospitalized at St. Olavs hospital and collect relevant information.

NCT ID: NCT03848273 Recruiting - Stroke Clinical Trials

Post Stroke Epileptic Seizures Risk Forecast

POSTER-1
Start date: February 20, 2019
Phase:
Study type: Observational

Improve the effectiveness of treatment and prognosis in patients with cerebrovascular accident by early detection of the risk of developing epileptic seizures.